Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.

Wolsk, Emil; Claggett, Brian; Pfeffer, Marc A; Diaz, Rafael; Dickstein, Kenneth; Gerstein, Hertzel C; Lawson, Francesca C; Lewis, Eldrin F; Maggioni, Aldo P; McMurray, John J V; Probstfield, Jeffrey L; Riddle, Matthew C; Solomon, Scott D; Tardif, Jean-Claude; Køber, Lars

Wolsk, Emil; Claggett, Brian; Pfeffer, Marc A; Diaz, Rafael; Dickstein, Kenneth; Gerstein, Hertzel C; Lawson, Francesca C; Lewis, Eldrin F; Maggioni, Aldo P; McMurray, John J V; Probstfield, Jeffrey L; Riddle, Matthew C; Solomon, Scott D; Tardif, Jean-Claude; Køber, Lars.

Afiliação

Wolsk E; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Claggett B; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Pfeffer MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Diaz R; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Dickstein K; Estudios Clínicos Latinoamérica, Rosario, Argentina.
Gerstein HC; University of Bergen Stavanger University Hospital, Stavanger, Norway.
Lawson FC; Division of Endocrinology & Metabolism, McMaster University, Hamilton, Ontario, Canada.
Lewis EF; Sanofi U.S., Bridgewater, NJ.
Maggioni AP; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
McMurray JJV; Research Center of the Italian Association of Hospital Cardiologists, Florence, Italy.
Probstfield JL; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom.
Riddle MC; Division of Cardiology, University of Washington Medical Center, Seattle, WA.
Solomon SD; Division of Endocrinology, Oregon Health and Science University, Portland, OR.
Tardif JC; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Køber L; Montreal Heart Institute, Université de Montréal, Montreal, Canada.

J Am Heart Assoc ; 6(6)2017 May 29.

Article em En | MEDLINE | ID: mdl-28554908

Assuntos

Síndrome Coronariana Aguda/sangue; Síndrome Coronariana Aguda/mortalidade; Diabetes Mellitus Tipo 2/sangue; Diabetes Mellitus Tipo 2/mortalidade; Peptídeo Natriurético Encefálico/sangue; Fragmentos de Peptídeos/sangue; Síndrome Coronariana Aguda/diagnóstico; Idoso; Biomarcadores/sangue; Causas de Morte; Diabetes Mellitus Tipo 2/diagnóstico; Feminino; Insuficiência Cardíaca/sangue; Insuficiência Cardíaca/mortalidade; Humanos; Masculino; Pessoa de Meia-Idade; Infarto do Miocárdio/sangue; Infarto do Miocárdio/mortalidade; Valor Preditivo dos Testes; Prognóstico; Estudos Prospectivos; Medição de Risco; Fatores de Risco; Acidente Vascular Cerebral/sangue; Acidente Vascular Cerebral/mortalidade; Fatores de Tempo

Palavras-chave

Evaluation of Lixisenatide in Acute Coronary Syndrome trial; Nterminal prohormone Btype natriuretic peptide; acute coronary syndrome; biomarker; brain natriuretic peptide; cardiac outcomes; diabetes mellitus; glucagonlike peptide1; natriuretic peptide; risk model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeo Natriurético Encefálico / Diabetes Mellitus Tipo 2 / Síndrome Coronariana Aguda Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google